Senior Manager, Market Access Japan ION

Primary Function of Position This role leads the clinical, economic, and access-focused evidence strategy for the Ion Business Unit for Japan. You own the Japan strategy that shows how Ion improves patient outcomes, care pathways, and health-system efficiency – and you use that evidence to unlock and scale access, reimbursement, and adoption. This role will work closely with APAC Commercial, Country GMs, Clinical Affairs, Product Management, Clinical Development Engineering, Medical Office, and Clinical Marketing, and collaborate with the Global Access Value and Economics (GAVE) and HEOR team. Key Responsibilities Set the Japan evidence & access strategy Define a 3–5 year clinical and economic evidence roadmap for Ion in Japan, linked to clear access, reimbursement, and adoption milestones in priority markets. Design and deliver high-impact evidence Lead design and prioritization of clinical and economic studies (clinical outcomes, RWE, cost-effectiveness, budget impact, pathway/resource use) that answer payer, HTA, hospital, and clinical decision-maker questions. Translate data into value stories Turn evidence into locally relevant value propositions, dossiers, slide decks, tools, and decision aids for payers, HTA bodies, hospital value committees, and clinical champions. Develop access pathways Develop Japan access plans (eg. HTA routes, innovation funding, direct payer contracting, hospital funding logic, coding/reimbursement context) and supply the Ion-specific evidence and analytics needed for submissions and negotiations, without owning pricing or commercial terms. Act as the Japan Ion “go-to” for evidence & access Work with cross-functional teams as the Japan Ion expert, and liaison to global headquarters. Shape the external environment Build and maintain senior relationships with KOLs, professional societies, payers, HTA agencies, and hospital decision-makers; selectively engage in consultations, guidelines, registries, and collaborative studies that move adoption barriers. Have worked closely with Ministry of Health, Labour, and Welfare (MHLW) and the Medical Economics Division and Central Social Insurance Medical Council (Chuikyo), PMDA, C2H National Institute of Public Health. Understand and have worked with Health Insurers, Medical Professional groups and Medical Academic Societies. Have worked with Industry Associations such as AMDD and EBC along with an understanding of Ministry of Finance and Cabinet level bodies. Lead teams, vendors, and budgets Provide leadership to direct reports and matrixed contributors. Select and manage HEOR/HTA/MA agencies, CROs, and data vendors. Own or co-own budgets and focus spend on initiatives with measurable access and adoption impact. Track impact and course-correct Define and monitor KPIs (e.g., HTA decisions, time to funding, procedure volume, contribution of evidence programs). Use policy, competitive, and clinical-trend insights to refine the Japan strategy over time. Required Advanced clinical, scientific, or health-economics degree (e.g., MD, PharmD, PhD, MPH, MSc in life sciences, health economics, public health, or related field). 10+ years’ progressive experience in clinical and economic evidence, HEOR, and/or market access for medical devices or interventional technologies, with significant responsibility in Japan. Proven track record contributing to successful reimbursement or funding outcomes in Japan (e.g., HTA submissions, innovation / pilot funding, coding or reimbursement changes, hospital funding decisions). Strong understanding of the Japan healthcare systems, payer and HTA decision-making, and hospital financing/procurement. Ability to connect product and procedural details to outcomes, operational impact, and economic value – and to communicate that succinctly to senior clinical and non-clinical stakeholders. Demonstrated success leading projects or multi-country initiatives and influencing senior leaders in a matrix environment. Excellent written and verbal communication in English; proficiency in Japanese language. Preferred Experience in robotic or minimally invasive technologies, interventional pulmonology, thoracic oncology, or related fields. Willingness and ability to travel across APAC and occasionally internationally. 当社は、法令に従い、全ての応募者について、その適性と能力のみを基準として公正に採用選考を行います。 この職位は、業務上のニーズや、採用候補者の経験、知識、技能に応じて、ここに記載されている職務レベルと異なるレベルで採用される場合があります。 報酬は、主に採用された職務レベルと候補者の資格に基づき、適用される法律に従って決定されます。